112
Views
16
CrossRef citations to date
0
Altmetric
Rapid Communication

Rapid Emergence of a Pandrug-Resistant Klebsiella pneumoniae ST11 Isolate in an Inpatient in a Teaching Hospital in China After Treatment with Multiple Broad-Spectrum Antibiotics

, , &
Pages 799-804 | Published online: 10 Mar 2020

References

  • Hu F, Zhu D, Wang F, Wang M. Current status and trends of antibacterial resistance in China. Clin Infect Dis. 2018;67(suppl_2):S128–S134. doi:10.1093/cid/ciy65730423045
  • Tumbarello M, Trecarichi EM, De Rosa FG, et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother. 2015;70(7):2133–2143. doi:10.1093/jac/dkv08625900159
  • Qi Y, Wei Z, Ji S, Du X, Shen P, Yu Y. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother. 2011;66(2):307–312. doi:10.1093/jac/dkq43121131324
  • Bassetti M, Giacobbe DR, Giamarellou H, et al. Management of KPC-producing Klebsiella pneumoniae infections. Clin Microbiol Infect. 2018;24(2):133–144. doi:10.1016/j.cmi.2017.08.03028893689
  • Logan LK, Weinstein RA. The epidemiology of carbapenem-resistant enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis. 2017;215(suppl_1):S28–S36. doi:10.1093/infdis/jiw28228375512
  • Pankey GA. Tigecycline. J Antimicrob Chemother. 2005;56(3):470–480. doi:10.1093/jac/dki24816040625
  • He F, Fu Y, Chen Q, et al. Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae. PLoS One. 2015;10(3):e0119064. doi:10.1371/journal.pone.011906425734903
  • Porreca AM, Sullivan KV, Gallagher JC. The epidemiology, evolution, and treatment of KPC-producing organisms. Curr Infect Dis Rep. 2018;20(6):13. doi:10.1007/s11908-018-0617-x29730830
  • Longo LGA, de Sousa VS, Kraychete GB, et al. Colistin resistance emerges in pandrug-resistant Klebsiella pneumoniae epidemic clones in Rio de Janeiro, Brazil. Int J Antimicrob Agents. 2019;54(5):579–586. doi:10.1016/j.ijantimicag.2019.08.01731479740
  • Sieswerda E, van den Brand M, van den Berg RB, et al. Successful rescue treatment of sepsis due to a pandrug-resistant, NDM-producing Klebsiella pneumoniae using aztreonam powder for nebulizer solution as intravenous therapy in combination with ceftazidime/avibactam. J Antimicrob Chemother. 2020;75(3):773–775.31789378
  • Zowawi HM, Forde BM, Alfaresi M, et al. Stepwise evolution of pandrug-resistance in Klebsiella pneumoniae. Sci Rep. 2015;5:15082. doi:10.1038/srep1508226478520
  • Avgoulea K, Di Pilato V, Zarkotou O. Characterization of extensively drug-resistant or pandrug-resistant sequence type 147 and 101 OXA-48-producing Klebsiella pneumoniae causing bloodstream infections in patients in an intensive care unit. Antimicrob Agents Chemother. 2018;62(7):e02457–17. doi:10.1128/AAC.02457-1729661874
  • Lazaro-Perona F, Sotillo A, Troyano-Hernaez P, Gomez-Gil R, de la Vega-Bueno A, Mingorance J. Genomic path to pandrug resistance in a clinical isolate of Klebsiella pneumoniae. Int J Antimicrob Agents. 2018;52(5):713–718. doi:10.1016/j.ijantimicag.2018.08.01230144503
  • Jia H, Chen H, Ruan Z. Unravelling the genome sequence of a pandrug-resistant Klebsiella pneumoniae isolate with sequence type 11 and capsular serotype KL64 from China. J Glob Antimicrob Resist. 2019;19:40–42. doi:10.1016/j.jgar.2019.08.01331449964
  • EUCAST. Clinical breakpoint tables for interpretation of MICs and zone diameters. Version 8.0. 2018.
  • Ruan Z, Feng Y. BacWGSTdb, a database for genotyping and source tracking bacterial pathogens. Nucleic Acids Res. 2016;44(D1):D682–D687. doi:10.1093/nar/gkv100426433226
  • Ruan Z, Yu Y, Feng Y. The global dissemination of bacterial infections necessitates the study of reverse genomic epidemiology. Brief Bioinform. 2019:1–10 doi:10.1093/bib/bbz01028981573
  • Alikhan NF, Petty NK, Ben Zakour NL, Beatson SA. BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons. BMC Genomics. 2011;12:402. doi:10.1186/1471-2164-12-40221824423
  • Jiang Z, Li M, Zhou D, et al. Sequencing and comparative genomics analysis of Klebsiella pneumoniae plasmid p1512-KPC. Acta Microbiol Sin. 2019;59(2):349–363.
  • Uz Zaman T, Albladi M, Siddique MI, Aljohani SM, Balkhy HH. Insertion element mediated mgrB disruption and presence of ISKpn28 in colistin-resistant Klebsiella pneumoniae isolates from Saudi Arabia. Infect Drug Resist. 2018;11:1183–1187. doi:10.2147/IDR.S16114630147346
  • Beabout K, Hammerstrom TG, Perez AM, et al. The ribosomal S10 protein is a general target for decreased tigecycline susceptibility. Antimicrob Agents Chemother. 2015;59(9):5561–5566. doi:10.1128/AAC.00547-1526124155
  • He F, Shi Q, Fu Y, Xu J, Yu Y, Du X. Tigecycline resistance caused by rpsJ evolution in a 59-year-old male patient infected with KPC-producing Klebsiella pneumoniae during tigecycline treatment. Infect Genet Evol. 2018;66:188–191. doi:10.1016/j.meegid.2018.09.02530268919